pyridoxamine has been researched along with Vascular Diseases in 5 studies
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxamine treatment prevents large artery stiffening with advancing age, but the effects of pyridoxamine treatment on the cerebral vasculature or cognition is unknown." | 1.91 | Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice. ( Colton Bramwell, R; Cullen, AE; Henson, GD; Khurana, A; Kronquist, EK; Lee, B; Machin, DR; Meza, A; Peterson, JA; Pham, H; Reeve, EH; Villasana, L; Walker, AE; Wolf, JR, 2023) |
| " Metabolic profile, NO bioavailability and vascular oxidative stress, AGE and Nrf2 levels were also assessed." | 1.46 | The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes. ( Crisóstomo, J; Fernandes, R; Pereira, A; Seiça, RM; Sena, CM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reeve, EH | 1 |
| Kronquist, EK | 1 |
| Wolf, JR | 1 |
| Lee, B | 1 |
| Khurana, A | 1 |
| Pham, H | 1 |
| Cullen, AE | 1 |
| Peterson, JA | 1 |
| Meza, A | 1 |
| Colton Bramwell, R | 1 |
| Villasana, L | 1 |
| Machin, DR | 1 |
| Henson, GD | 1 |
| Walker, AE | 1 |
| Pereira, A | 1 |
| Fernandes, R | 1 |
| Crisóstomo, J | 1 |
| Seiça, RM | 1 |
| Sena, CM | 1 |
| Kuzan, A | 1 |
| Chwiłkowska, A | 1 |
| Kobielarz, M | 1 |
| Pezowicz, C | 1 |
| Gamian, A | 1 |
| Jakus, V | 1 |
| Rietbrock, N | 1 |
| Ahmed, N | 1 |
| Thornalley, PJ | 1 |
3 reviews available for pyridoxamine and Vascular Diseases
| Article | Year |
|---|---|
[Glycation of extracellular matrix proteins and its role in atherosclerosis].
Topics: Arteries; Atherosclerosis; Biomechanical Phenomena; Collagen; Connective Tissue; Elasticity; Extrace | 2012 |
Advanced glycation end-products and the progress of diabetic vascular complications.
Topics: Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Glyco | 2004 |
Advanced glycation endproducts: what is their relevance to diabetic complications?
Topics: Blood Glucose; Diabetes Complications; Glycation End Products, Advanced; Glycosylation; Humans; Hype | 2007 |
2 other studies available for pyridoxamine and Vascular Diseases
| Article | Year |
|---|---|
Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice.
Topics: Aging; Animals; Cerebral Arteries; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Pyridoxami | 2023 |
The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes.
Topics: Animals; Aorta; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Endothelium; | 2017 |